-+ 0.00%
-+ 0.00%
-+ 0.00%

DISCO PHARMACEUTICALS: ON COMPLETION OF SPECIFIED RESEARCH, ABBVIE TO HAVE OPTION TO EXCLUSIVELY LICENSE SELECTED PROGRAMS FOR FURTHER DEVELOPMENT

Reuters·11/19/2026 07:00:00

Please log in to view news